Status:
RECRUITING
Establishment of Biobank of Nasal Epithelium Samples From Healthy Volunteers
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Healthy
Eligibility:
All Genders
18-99 years
Brief Summary
Background: Infections in the lower respiratory tract (lungs) are the leading cause of death from infectious disease worldwide. This was true even before the COVID-19 pandemic. Respiratory viruses ar...
Detailed Description
Study Description: This is a repository protocol with prospective sample collection to provide samples needed for future studies of the pathogenesis of emerging respiratory viruses. Nasal brushings w...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Aged \>=18 years.
- Able to provide informed consent.
- Willing to allow biological samples and data to be stored for future research.
- EXCLUSION CRITERIA:
- An individual who meets any of the following criteria will be excluded from participation in this
- study:
- History of respiratory symptoms including but not limited to runny nose, coughing, congestion, and/or fever within the past 14 days.
- NIH and laboratory staff with direct involvement in the operation or maintenance of the repository are excluded from participation.
- An individual who has any condition that, in the judgment of the investigator, may put them at undue risk or make them unsuitable for participation in the study will be excluded.
Exclusion
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2033
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06120244
Start Date
November 1 2023
End Date
October 31 2033
Last Update
July 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rocky Mountain Laboratories
Hamilton, Montana, United States, 59840